Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.21% | 159.65 | 0.7% | $1260.61m | |
| PFE | Pfizer Inc. | 0.40% | 33.67 | 0.9% | $1163.42m | |
| BMY | Bristol-Myers Squibb Co. | -0.19% | 61.52 | 1.0% | $829.03m | |
| MRK | Merck & Co., Inc. | 0.84% | 72.99 | 0.7% | $826.12m | |
| ABBV | AbbVie, Inc. | 0.35% | 108.79 | 1.9% | $772.04m | |
| LLY | Eli Lilly & Co. | -0.05% | 206.37 | 1.1% | $677.33m | |
| AZN | AstraZeneca Plc | -0.50% | 47.85 | 1.2% | $496.20m | |
| GSK | GlaxoSmithKline Plc | 1.48% | 34.23 | 0.2% | $282.32m | |
| NVS | Novartis AG | 2.18% | 88.46 | 0.2% | $176.03m | |
| SNY | Sanofi | 0.46% | 46.12 | 0.2% | $167.21m | |
| VTRS | Viatris, Inc. | -3.45% | 14.21 | 0.0% | $140.11m | |
| VERU | Veru, Inc. | -1.77% | 14.16 | 0.0% | $123.12m | |
| CVAC | CureVac NV | -3.67% | 92.66 | 0.0% | $92.37m | |
| NVO | Novo Nordisk A/S | 0.21% | 72.79 | 0.1% | $92.11m | |
| KALV | KalVista Pharmaceuticals, Inc. | -2.96% | 32.44 | 0.4% | $88.23m |
Company Profile
Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.